• ABT-263 (Navitoclax): Unveiling Apoptosis Sensors Beyond ...

  2025-09-30

  Unlock the advanced science behind ABT-263 (Navitoclax), a potent Bcl-2 family inhibitor, and discover novel insights into apoptosis regulation and mitochondrial signaling. This article uniquely explores apoptosis sensing mechanisms that extend beyond classical Bcl-2 inhibition, offering new directions for cancer biology research.

• PD0325901: Redefining MEK Inhibition in Cancer and Stem C...

  2025-09-29

  Explore how PD0325901, a selective MEK inhibitor, uniquely advances cancer and stem cell research through precision RAS/RAF/MEK/ERK pathway inhibition and innovative mechanistic insights. This article provides a deeper, integrative perspective on apoptosis induction and cell cycle arrest, setting it apart from previous analyses.

• RSL3 as a Precision GPX4 Inhibitor: Decoding Ferroptosis ...

  2025-09-28

  Explore how RSL3, a potent glutathione peroxidase 4 inhibitor, enables targeted ferroptosis induction in cancer research. This article uniquely integrates emerging mechanistic insight with translational perspectives, highlighting novel intersections between ferroptosis, apoptosis, and oncogenic RAS vulnerabilities.

• PD0325901: Pioneering MEK Inhibition for Precision Cancer...

  2025-09-27

  Explore how PD0325901, a selective MEK inhibitor, advances cancer research through targeted RAS/RAF/MEK/ERK pathway inhibition, apoptosis induction, and innovative applications in stem cell and melanoma models. Discover fresh insights distinct from previous analyses.

• CHIR 99021 Trihydrochloride: Advancing Precision Organoid...

  2025-09-26

  Explore how CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor, is revolutionizing organoid engineering and metabolic disease modeling through its precise modulation of stem cell fate. This article provides an in-depth, mechanistic perspective and highlights novel experimental strategies beyond standard applications.

• Bortezomib (PS-341): A Molecular Gateway to Apoptosis Bey...

  2025-09-25

  Explore how Bortezomib (PS-341), a leading reversible proteasome inhibitor, not only targets cancer therapy but also reveals a novel, mitochondria-linked programmed cell death mechanism. This article offers a unique molecular perspective for researchers investigating apoptosis assays and proteasome-regulated cellular processes.

• HyperScribe™ Poly (A) Tailing Kit: Enabling Functional mR...

  2025-09-24

  Explore how the HyperScribe™ Poly (A) Tailing Kit empowers advanced mRNA research by combining polyadenylation of RNA transcripts with enhanced translation efficiency, enabling functional genomics, metastasis modeling, and novel cell biology applications. Discover a deeper scientific perspective on post-transcriptional RNA processing.

• VX-765 in Caspase-1 Signaling: Distinguishing Pyroptosis ...

  2025-09-23

  Explore the unique utility of VX-765, a selective caspase-1 inhibitor, in dissecting inflammatory pyroptosis versus apoptotic cell death. This article details how VX-765 informs cytokine modulation and cell death pathway research, with emphasis on current mechanistic discoveries.

• Heat shock protein Hsp is a

  2025-03-03

  

  Heat shock protein 90 (Hsp90) is a molecular chaperone that plays a central role in regulating the maturation, activation and stability of numerous “client proteins” that drive the development and progression of many cancers. Therefore, inhibition of Hsp90 would result in degradation of the client p

• ATP assay kit luciferase Implicit in this concept is the

  2025-03-03

  

  Implicit in this concept is the idea that the β-adrenoceptors in the detrusor would be activated by adrenergic nerves of the sympathetic system: sympathetic activity promoting relaxation and enhancing bladder capacity. However, it has been demonstrated that there is only a sparse adrenergic innervat

• While HTPCs are not immune cells they

  2025-03-03

  

  While HTPCs are not immune cells, they produce IL-6, MCP-1 and other immunologically relevant factors (Mayer et al., 2016). Our results demonstrated that epinephrine and phenylephrine increased the mRNA expression levels of COX-2, IL-6 and MCP-1 in HTPCs without affecting the mRNA expression level o

• br Experimental section br Results

  2025-03-03

  

  Experimental section Results and discussion Conclusion Acknowledgements This work was financially supported by Recruitment Program of Global Experts, and the Director Foundation of XTIPC, CAS, Grant No. 2015RC011. This work was also financially supported by Natural Science Foundation of

• Thus one possible target for CRPC

  2025-03-03

  

  Thus one possible target for CRPC treatment is the enzyme 17,20-lyase, which plays a crucial role in androgen biosynthesis. This is because inhibition of 17,20-lyase would be expected to decrease serum androgen levels secreted not only by the testes but also by the adrenal glands.7, 8, 9 In recent

• As shown in B the recombinant human LOX nM

  2025-03-01

  

  As shown in B, the recombinant human 15-LOX-1 (30nM) showed a time-dependent increase in fluorescent signal, and signal development was almost completed within 20min in the presence of 50μM arachidonic fruquintinib and 5μM DHR. For both purified enzyme and cell lysates, the enzyme activities disapp

• br Colorectal carcinoma The growth rate of murine

  2025-03-01

  

  Colorectal carcinoma The growth rate of murine colon adenocarcinoma tumors decreased upon inhibition of 5-LOX, an enzyme that harbors counteracting properties to 15-LOX [28]. It is not clear whether 15-LOX was associated with this phenomenon, but its expression is induced in the colon carcinoma c

8476 records 39/566 page Previous Next First page 上5页 3637383940 下5页 Last page